Pu YS - Search Results

Year	Number of Results
1991	1
1993	1
1994	2
1995	5
1996	2
1998	1
1999	7
2000	2
2001	6
2002	4
2003	1
2004	5
2005	4
2006	10
2007	21
2008	17
2009	16
2010	12
2011	19
2012	21
2013	20
2014	20
2015	16
2016	14
2017	13
2018	14
2019	8
2020	12
2021	11
2022	10
2023	11
2024	3

1

Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023.

Chiong E, Murphy DG, Buchan N, Chen K, Chen SS, Chua MLK, Hamid AR, Kanesvaran R, Khochikar M, Letran J, Lojanapiwat B, Mallik I, Ng CF, Ong TA, Poon DMC, Pu YS, Saad M, Schubach K, Takahara K, Tey J, Thang SP, Toh PC, Türkeri L, Vinh NT, Williams S, Ye D; ANZUP Cancer Trials Group; Davis ID. Chiong E, et al. Among authors: pu ys. Asia Pac J Clin Oncol. 2024 Apr 16. doi: 10.1111/ajco.14064. Online ahead of print. Asia Pac J Clin Oncol. 2024. PMID: 38628049

2

C-C chemokine receptor 4 (CCR4)-positive regulatory T cells interact with tumor-associated macrophages to facilitate metastatic potential after radiation.

Chiang Y, Lu LF, Tsai CL, Tsai YC, Wang CC, Hsueh FJ, Huang CY, Chen CH, Pu YS, Cheng JC. Chiang Y, et al. Among authors: pu ys. Eur J Cancer. 2024 Feb;198:113521. doi: 10.1016/j.ejca.2023.113521. Epub 2023 Dec 24. Eur J Cancer. 2024. PMID: 38171115 Free article.

3

EGFR-mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells.

Pu YS, Huang CY, Wu HL, Wu JH, Su YF, Yu CR, Lu CY, Wu WJ, Huang SP, Huang YT, Hour TC. Pu YS, et al. Kaohsiung J Med Sci. 2024 Jan;40(1):23-34. doi: 10.1002/kjm2.12766. Epub 2023 Nov 2. Kaohsiung J Med Sci. 2024. PMID: 37916740 Free article.

4

Active Surveillance for Taiwanese Men with Localized Prostate Cancer: Intermediate-Term Outcomes and Predictive Factors.

Hong JH, Kuo MC, Cheng YT, Lu YC, Huang CY, Liu SP, Chow PM, Huang KH, Chueh SJ, Chen CH, Pu YS. Hong JH, et al. Among authors: pu ys. World J Mens Health. 2023 Sep 26. doi: 10.5534/wjmh.230107. Online ahead of print. World J Mens Health. 2023. PMID: 37853534 Free article.

5

Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.

Huang HP, Chen CH, Chang KH, Lee MS, Lee CF, Chao YH, Lu SY, Wu TF, Liang ST, Lin CY, Lin YC, Liu SP, Lu YC, Shun CT, Huang WJ, Lin TP, Ku MH, Chung HJ, Chang YH, Liao CH, Yu CC, Chung SD, Tsai YC, Wu CC, Chen KC, Ho CH, Hsiao PW, Pu YS. Huang HP, et al. Among authors: pu ys. J Transl Med. 2023 Oct 11;21(1):714. doi: 10.1186/s12967-023-04424-9. J Transl Med. 2023. PMID: 37821919 Free PMC article.

6

Primary Total Prostate Cryoablation for Localized High-Risk Prostate Cancer: 10-Year Outcomes and Nomograms.

Chen CH, Tsai CY, Pu YS. Chen CH, et al. Among authors: pu ys. Cancers (Basel). 2023 Jul 30;15(15):3873. doi: 10.3390/cancers15153873. Cancers (Basel). 2023. PMID: 37568689 Free PMC article.

7

Survival outcomes and prognostic factors for first-line abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer.

Tseng CS, Yang JH, Huang SW, Wang YJ, Chen CH, Pu YS, Cheng JC, Huang CY. Tseng CS, et al. Among authors: pu ys. BMC Cancer. 2023 Jun 20;23(1):568. doi: 10.1186/s12885-023-10885-4. BMC Cancer. 2023. PMID: 37340337 Free PMC article.

8

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma.

Jhuang JR, Chiu PC, Hsieh TC, Chen CH, Pu YS, Lee WC. Jhuang JR, et al. Among authors: pu ys. Front Public Health. 2023 Mar 9;11:1072864. doi: 10.3389/fpubh.2023.1072864. eCollection 2023. Front Public Health. 2023. PMID: 36969664 Free PMC article.

9

Possible Combined Effects of Plasma Folate Levels, Global DNA Methylation, and Blood Cadmium Concentrations on Renal Cell Carcinoma.

Huang CY, Chen WJ, Lee HL, Lin YC, Huang YL, Shiue HS, Pu YS, Hsueh YM. Huang CY, et al. Among authors: pu ys. Nutrients. 2023 Feb 13;15(4):937. doi: 10.3390/nu15040937. Nutrients. 2023. PMID: 36839294 Free PMC article.

10

Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling.

Tsai YC, Wang TY, Hsu CL, Lin WC, Chen JY, Li JH, Pu YS, Cheng AL, Cheng JC, Su SF. Tsai YC, et al. Among authors: pu ys. Br J Cancer. 2023 May;128(9):1753-1764. doi: 10.1038/s41416-023-02195-0. Epub 2023 Feb 21. Br J Cancer. 2023. PMID: 36810912 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

262 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Results by year